Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Black Diamond Therapeutics, Inc. | 30,550 | reported | 12 Jun 2025 | tx 6+137,442 |
| CANCERVAX CORP | 25,000 | reported | 23 Jun 2011 | tx 4+90,000 |
| LAVA Therapeutics NV | 0 | reported | 13 Nov 2025 | tx 3+33,390−63,390 |
| FIVE PRIME THERAPEUTICS INC | 0 | reported | 16 Apr 2021 | tx 11+90,000−80,000 |
| Replimune Group, Inc. | 0 | reported | 09 Dec 2025 | tx 16+208,869−86,338 |
| CARGO Therapeutics, Inc. | 0 | reported | 19 Aug 2025 | tx 4+86,136−25,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Dec 2025 | SALE | Replimune Group, Inc. | 3,169 | 10.40 USD | |
| 09 Dec 2025 | EXERCISE | Replimune Group, Inc. | 3,169 | 1.75 USD | |
| 09 Dec 2025 | EXERCISE | Replimune Group, Inc. | 3,169 | 0.00 USD | deriv |
| 13 Nov 2025 | OTHER | LAVA Therapeutics NV | 30,000 | — | |
| 13 Nov 2025 | OTHER | LAVA Therapeutics NV | 33,390 | 0.00 USD | deriv |
| 19 Aug 2025 | OTHER | CARGO Therapeutics, Inc. | 25,000 | — | deriv |
| 18 Jun 2025 | GRANT_AWARD | CARGO Therapeutics, Inc. | 25,000 | 0.00 USD | deriv |
| 12 Jun 2025 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 30,550 | 0.00 USD | deriv |
| 01 Apr 2025 | GRANT_AWARD | Replimune Group, Inc. | 32,000 | 0.00 USD | deriv |
| 13 Feb 2025 | GRANT_AWARD | LAVA Therapeutics NV | 33,390 | 0.00 USD | deriv |
| 06 Jun 2024 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 30,550 | 0.00 USD | deriv |
| 04 Jun 2024 | GRANT_AWARD | CARGO Therapeutics, Inc. | 11,871 | 0.00 USD | deriv |
| 15 Apr 2024 | GRANT_AWARD | CARGO Therapeutics, Inc. | 49,265 | 0.00 USD | deriv |
| 01 Apr 2024 | GRANT_AWARD | Replimune Group, Inc. | 32,000 | 0.00 USD | deriv |
| 16 May 2023 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 16,500 | 0.00 USD | deriv |
| 01 Apr 2023 | GRANT_AWARD | Replimune Group, Inc. | 25,200 | 0.00 USD | deriv |
| 10 Jun 2022 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 01 Apr 2022 | GRANT_AWARD | Replimune Group, Inc. | 16,500 | 0.00 USD | deriv |
| 18 Jun 2021 | GRANT_AWARD | Black Diamond Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 16 Apr 2021 | OTHER | FIVE PRIME THERAPEUTICS INC | 25,000 | — | deriv |
| 16 Apr 2021 | OTHER | FIVE PRIME THERAPEUTICS INC | 10,000 | — | deriv |
| 16 Apr 2021 | OTHER | FIVE PRIME THERAPEUTICS INC | 20,000 | — | deriv |
| 16 Apr 2021 | OTHER | FIVE PRIME THERAPEUTICS INC | 15,000 | — | deriv |
| 16 Apr 2021 | OTHER | FIVE PRIME THERAPEUTICS INC | 10,000 | — | deriv |
| 01 Apr 2021 | GRANT_AWARD | Replimune Group, Inc. | 16,500 | 0.00 USD | deriv |